Table 3.

Multiple stepwise logistic regression of risk factors of target organ damage in the overall studied population.

Variance		β	SE	Exp β	95% CI	P value
CIMT abnormality	Age	0.087	0.008	1.091	1.073–1.108	<0.001
	Sex	−0.636	0.183	0.530	0.370–0.758	0.001
	Antihypertensive drugs (yes or no)	0.548	0.167	1.730	1.247–2.401	0.001
	FBG	0.121	0.054	1.129	1.015–1.255	0.025
LVH	Age	0.052	0.008	1.054	1.038–1.070	<0.001
	Sex	0.758	0.198	2.134	1.448–3.145	<0.001
	BMI	0.065	0.024	1.067	1.017–1.119	0.008
	cSBP	0.013	0.007	1.013	1.000–1.026	0.053
	cAIx@HR75	−0.041	0.012	0.959	0.936–0.983	0.001
CKD	Age	0.049	0.021	1.050	1.008–1.093	0.018
	cf-PWV	0.265	0.088	1.303	1.096–1.550	0.003
ACR abnormality	Antihypertensive drugs (yes or no)	0.593	0.233	1.810	1.145–2.859	0.011
	FBG	0.147	0.052	1.158	1.046–1.282	0.005
	cSBP	0.033	0.007	1.034	1.020–1.048	<0.001

All variables adjusted for age, sex (male or female), height, BMI, body mass index, smoking history, antihypertensive drugs (yes or no), HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; FBG, fasting blood glucose; pMAP, peripheral mean arterial pressure; HR, heart rate beats per minute; VIF, variance inflation factor.

The bold values represent the values that are statistically significant (P < 0.05).